You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 5, 2024

Drugs Containing Excipient (Inactive Ingredient) ASPARTIC ACID

✉ Email this page to a colleague

« Back to Dashboard

Branded drugs containing ASPARTIC ACID excipient, and estimated key patent expiration / generic entry dates

Subscribe to access the full database, or Sign Up
Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Long Grove Pharmaceuticals LLC	VASOPRESSIN IN 0.9% SODIUM CHLORIDE	vasopressin	81298-8552	ASPARTIC ACID
>Company	>Tradename	>Ingredient	>NDC	>Excipient	>Potential Generic Entry

Generic drugs containing ASPARTIC ACID excipient

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC	Excipient
Baxter Healthcare Corporation	famotidine	0338-5197	ASPARTIC ACID
Hikma Pharmaceuticals USA Inc	famotidine	0641-6021	ASPARTIC ACID
Genentech Inc	satralizumab	50242-007	ASPARTIC ACID
Genentech Inc	crovalimab	50242-115	ASPARTIC ACID
Genentech Inc	emicizumab	50242-920	ASPARTIC ACID
>Company	>Ingredient	>NDC	>Excipient

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.